PAMI Risk Score: Comprehensive Explanation and Clinical Context
The PAMI (Primary Angioplasty in Myocardial Infarction) Risk Score is a clinical tool developed to predict 30-day mortality in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). It uses seven readily available clinical variables: age, comorbidities, heart rate, systolic blood pressure, Killip class, infarct location, and delay to treatment.
Higher scores indicate increased short-term mortality risk and the need for more intensive monitoring and supportive therapy. The PAMI Score remains a useful bedside tool despite the evolution of PCI technology and adjunctive pharmacotherapy.
References: 1. Addala S, Grines CL, Dixon SR, et al. Predicting mortality in patients with STEMI undergoing primary angioplasty: the PAMI Risk Score. Am J Cardiol. 2004;93(5):629–632.
2.
Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993;328(10):673–679.
3.
Mehta RH, et al. Risk assessment in acute coronary syndromes and the role of risk scores. Am Heart J. 2007;154(1):21–28.